Our data indicate that most of the TLR3-expressing immune cells were macrophages and, in contrast to that observed in tumor cells, stromal tumor-infiltrating immune cells that expressed TLR3 (TLR3-s) were strongly significantly associated with a poor prognosis in NSCLC in the univariate and multivariate analyses. The gene discussed is TLR3; the disease is neoplasm.